Immune Tolerance Induction Study

Clinical trial NCT00701701 · TERMINATED

Trial details

NCT number: NCT00701701
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Pompe Disease Glycogen Storage Disease Type II (GSD-II)Glycogenesis 2 Acid Maltase Deficiency

Start date: 2008-12-14
Primary completion: 2020-02-18
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.